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Aim: Anorexia Nervosa (AN) is a complex and clinically challenging syndrome. Intended for specialist audiences,
this narrative review aims to summarise the available literature related to assessment in the adult patient context,
synthesising both research evidence and clinical consensus guidelines.
Method: We provide a review of the available literature on specialist assessment of AN focusing on common
trajectories into assessment, obstacles accessing assessment, common presenting issues and barriers to the
assessment process, the necessary scope of assessment, and tools and techniques. It describes the further step of
synthesising assessment information in ways that can inform resultant care plans.
Results: In addition to assessment of core behaviours and diagnostic skills, considerations for the expert assessor
include the functions of primary care, systemic and personal barriers, knowledge of current assessment tools and
research pertaining to comorbid pathology in AN, assessing severity of illness, role of family at assessment, as well
as medical, nutritional and compulsory elements of assessment.
Conclusion: Comprehensive assessment of AN in the current healthcare context still remains largely the remit of
the specialist ED clinician. Assessment should remain an on-going process, paying particular attention to available
empirical evidence, thereby reducing the gap between research and practice.
Keywords: Anorexia nervosa, Assessment, Eating disordersIntroduction
Most health workers recognise that anorexia nervosa
(AN) is a serious disorder that results in significant dis-
ability and impaired quality of life. Unfortunately for some,
this disorder becomes a chronic or life-shortening illness.
It is well-established that AN has the highest mortality
rate of all psychiatric disorders [1]; compared with their
peers without the illness the risk of premature death is ap-
proximately ten-fold in a person with AN [2]. Health con-
sequences are widespread, both in terms of direct physical
and mental health effects and economic costs to society
overall; a recent Australian analysis placed the total yearly
direct health system costs of AN at $59.8 million [3]. This
means that although AN and AN-like conditions are rela-
tively rare, severe and enduring forms of AN have impair-
ment outcomes comparable to people with moderately
severe depression and schizophrenia [3].* Correspondence: lois.surgenor@otago.ac.nz
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distribution, and reproduction in any mediumAssessment and a resulting early diagnosis become a
vital task for the health system and current research
continues to suggest that, although primary care is the
context of most presentation [4] areas with specialist
services have more than double the number of diagnos-
able eating disorder (ED) cases, suggesting a sizeable
proportion of diagnoses do not occur until the specialist
service level [5]. What this means for both settings is
worth discussion, but regardless, assessment skills and
knowledge of the evidence base pertaining to diagnoses
remain an important part of the skill set of the specialist
clinician.
Regardless of the setting and complexity, there are
descriptions of ‘ideal practice’ in the assessment of the
disorder and associated health difficulties. However,
assessment approaches do vary, along with models of
service delivery, admission thresholds and the resources
available in specialist settings [5]. Such factors will influ-
ence the composition of a multidisciplinary assessment
team. There are suggestions about what constitutes and Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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recommended components, and multiple tasks may fall to
‘mini teams’ [6]. There is however areas of general consen-
sus about many necessary and desirable tasks of assess-
ment and given the above constraints it often falls to the
specialist clinician working in relative isolation to be well
versed in all factors pertinent to a comprehensive assess-
ment. Focusing primarily on adult populations, this paper
aims to reduce the gap between research and practice
(as it relates to assessment of AN) by firstly providing a
comprehensive review of the current literature relating
to assessment pathways, barriers to assessment, diag-
nostic issues, instruments for assessment of illness and
severity, role of the family at assessment, comorbid pre-
sentations relevant to assessment, medical, nutritional
and compulsory assessment practises. Secondly, it dis-
cusses the process of synthesising information gathered
at assessment for the purposes of formulation and
ultimately to direct treatment.
Pathways to assessment
Links with primary care providers
Given the scarcity of specialist ED services, most people
with AN will not be seen by a specialist service in the
first instance, and for a significant number, specialist
assessment may not occur at any stage. Half of those
with an ED are first diagnosed by their primary care
physician, although of concern a sizeable minority may
go through life without any help whether this is for AN
or other emotional problems [4]. General practitioners
(GPs) and other primary health care providers are best
placed to be the health practitioners first involved in
conducting preliminary assessments, providing initial
triage, and thereafter sharing case management with
other clinicians [7]. This is partly because people with
eating disorders attend GPs and other medical speciality
services more frequently than their peer group, albeit
often for conditions seemingly unrelated to the disorder.
The presence of an ED also increases the rate of presen-
tations to Emergency Departments [4]. In terms of ac-
curacy of diagnosis, AN is the ED most often accurately
diagnosed by primary care physicians [8]. Atypical cases,
or those who do not present with all diagnostic criteria,
can be misdiagnosed [9] or considered ‘less serious’
despite clearly having a clinically significant disorder that
squarely sits within the AN spectrum.
A number of obstacles arise for primary care health
professionals in their attempt to detect AN and refer on
to ED services. Setting obstacles include the limited con-
sultation time available and relatively limited exposure
to AN. Clinical obstacles include patient minimisation of
behavioural and psychological symptoms, the diversity of
symptom expression, and well-hidden symptoms [7].
Further, there may be difficulty in determining whichsymptoms are most important in assessing medical
acuity or how severe the condition has become.
Systemic issues also contribute to rates of diagnosis
and their accuracy. GP education about risk factors and
early warning signs as well as screening instruments like
the SCOFF [10] can assist detection and management,
particularly where GPs are expected to coordinate and
manage concurrent medical and psychiatric conditions.
Close and regular liaison with ED specialists may
encourage more regular enquiry about eating difficulties
in those who frequently present with emotional and/or
physical problems. GPs are referral “gatekeepers” (whether
intended or otherwise), and ED clinicians have a role in
supporting and educating their colleagues about frontline
assessment practices and referral thresholds. In the
regions where there are specialist services, GPs are likely
to have greater awareness of eating disorders and in turn
refer to specialist services more frequently [6]. In any
event, presentation to primary care or emergency services
should always be used as an opportunity to introduce, or
re-engage with an ED clinician or ED service if one is
available.
Facilitating assessment following referral
Early identification and treatment of AN is consistently
argued as a means to reduce the duration of AN [11,12].
A systematic review of treatment seeking has recently
estimated that the median delay from onset to treatment
for AN is 15 years [13]. Identifying the barriers between
these two time points becomes pivotal, and will likely
vary. A significant minority of people referred for ED
problems fail to attend an initial assessment [14], and
further significant attrition occurs between assessment
and providing and/or completing treatment. The following
sections discuss common obstacles and possible solutions.
System and resource barriers
There are extensive system factors contributing to delays
in accessing assessment. The shortage of services often
results in prolonged waiting lists for assessment, mean-
ing that by the time of assessment, patients may be
demotivated or otherwise less likely to engage in what is
offered. Tatham et al. [15] trialled an active ‘opt in’
waitlist management strategy for an ED clinic, whereby
following initial assessment patients were required to
actively select to remain on the waitlist for treatment.
While ‘opting in’ letters may reduce the waiting time for
an assessment [16], this triage approach is not without
significant risk. Specifically, those most in need of
assessment may be the least able or willing to ‘opt in’.
Long assessment waiting lists are likely to pose a barrier
to engaging in any subsequent assessment - just as these
do in many other health settings. It has been reported by
patients that this can send a distorted message that the
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caught in the ethical dilemma of setting priorities for how
scarce resources should be allocated and prioritised. As
these decisions have major clinical implications, resource
priority-setting should be reviewed at regular intervals.
Suggested strategies that have been shown to increase the
likelihood of a valid referral resulting in an assessment in-
clude direct phone contact with the patient [14] accurate
written knowledge services and, where appropriate, steps
to engage significant others (for example, family) in the
assessment process [11].
Barriers of ambivalence and motivation
There are multiple psychological reasons why people
with AN may be reluctant to present for assessment or
are guarded during an assessment. The disorder itself, at
best, presents genuine ambiguity for many who suffer
from it. As one woman described it, “I want to get rid of
the disorder but not the body shape (of AN)…I want the
best of both worlds” [17], page 29. AN has been demon-
strated to serve more pivotal functions of affect numbing
or identity and the individual may see no reason to alter
it at all or, as is most common, the patient may move
between wanting to address it and not seeing it as a
problem. This ambivalence is complex and may shift
even in the preliminary assessment interview. The inter-
view may be infused with ‘bargaining points’ or requests
for ‘conditional’ or no treatment at all. With these dynam-
ics at play, careful clinical skills are required. It is import-
ant that such bargaining is not seen as ‘manipulation’ with
the negative connotations of that concept. Rather, it
represents a genuine struggle with symptoms that are
both controlling and out of control, and at times deeply
confusing for the person. It can be very validating to the
client, and move the process of assessment along
smoothly, to express understanding for the two seem-
ingly opposite positions that can be held within the one
person, and to not dismiss or invalidate the part of the
client that wants to retain the illness. Family and carers
may be equally conflicted about the need for treatment,
with parents sometimes caught between loyalty for their
offspring and wanting to heed professional advice.
Assessment of family functioning is discussed later in
this paper.
Although overlapping with ambivalence, motivation is
a wider construct involving cognitive, behavioural, and
biological systems. Appraising motivation for treatment
and ability to change is an important component of any
initial assessment: it often contributes to case formula-
tion, decisions made at the conclusion of assessment,
and subsequent treatment planning. Yet assessment of
this is far from straight forward. Motivation may be
symptom-specific: there may be high engagement in
strategies to control physical side effects, but minimalengagement in behaviours directed towards weight gain.
Engaging in conversations that highlight this variability
at the beginning of a therapeutic interaction is likely to
build alliance. As noted by [18], assessing what makes
people want to recover, and what recovery represents to
them, is important, and this is something highly valued
by patients themselves.
Of note, there is controversy regarding the ability of
clinicians to accurately assess motivation, and whether
this predicts anything about the likelihood of engage-
ment or even treatment outcome. Waller [19] provides a
compelling overview of the complexities involved, includ-
ing clinician overreliance on verbal expressions of change.
Interestingly, similar critical analyses are now being ex-
tended to motivational enhancement techniques, noting
that in regard to AN, the evidence is mixed at best [20].
Rieger et al. [21] specifically suggests motivation is not
only required to alter the behavioural aspects of the illness
(namely how much weight are patients are prepared to
gain each week until they reach a healthy weight, and
how motivated they feel to be at a normal weight) but
also feeling of self-efficacy about achieving this. Some
patients will state that they are very motivated to be at a
normal weight and would be prepared to gain up to a
kilo a week to do so, but when asked how confident they
are that they can actually do this, the answer is quite
different.
Clinicians as barriers
People presenting for assessment are often fearful of be-
ing judged or criticised. These fears are not unfounded
as it has been repeatedly demonstrated that attitudes of
health professionals, including mental health specialists
towards EDs, are not always positive [22], and are no
more empathic than those of non-professionals [23].
Negative professional attitudes may arise through lack of
training or experience [24], inadequate resources and
work pressure, and genuinely held stereotypes about AN
being a personal choice. These factors can contribute to
AN being seen as a disorder with relatively low prestige
by health care professionals [25]. Training and support
strategies may go some way to counter these effects. As
clinical experience decreases the likelihood of negative
reactions, services significantly benefit from retaining
highly skilled staff.
Early drop-out
Failure to engage, or drop out once treatment begins has a
negative association with prognosis [26,27] and increases
the likelihood of intensive treatment utilisation in later
stages of illness [28]. Specialist services have lower treat-
ment drop out and allow greater continuity of care with
the same service, yet studies suggest that amongst those
with EDs who actually attend assessment, approximately
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able predictors (clinical or otherwise) of drop-out from
services are scarce [17,26,30], meaning that future assess-
ment interviews should be seen as an opportunity to ex-
plore the factors involved from the patient’s perspective.
Hudson et al. [31] found life-time treatment for AN to be
33.8%, and thus much lower than other DSM-IV eating
disorders (BN 43.2%; BED 43.6). Reducing drop-out before
and after assessment is an obvious means to increase
treatment take-up.
Diagnostic issues at assessment
AN is a syndrome involving considerable symptom vari-
ability between and within cases over time. Cross-over
between AN subtypes is common, suggesting that those
with AN-Restricting Type and AN-Binge-Eating/Purging
Type may be phases of the same condition rather than
distinct groups [32]. Diagnostic weight cut-offs are de-
bated [9] and the severity of psychological versus physical
symptomatology may not always highly correlate, albeit
these will be highly intertwined at extremely low weights
due to the behavioural, psychological, and cognitive effects
of starvation [33]. The following sections discuss key
issues regarding diagnostic variability.
Revised diagnostic criteria
The American Psychiatric Association diagnostic criteria
(DSM-5) [34] have recently been reviewed. Hebebrand
et al. [9] comprehensively discusses the rationale behind
revised criteria, highlighting the reframing of psychological
symptoms so that some pejorative attitudes are removed
and other criteria are redefined to reflect the evidence. For
example, eliminating the term ‘refusal’ (to maintain body
weight), and replacing this with more objective terms de-
scribing food restriction. The removal of the diagnostic
criteria of amenorrhea in post-menarcheal females is well
overdue given the mounting evidence that this is of ques-
tionable utility. Similar changes are proposed for ICD-11
[35]. Clinicians involved in the assessment of AN should
become familiar with current and future diagnostic de-
bates in order to reduce the risk of adopting a rigid or
outdated approach to formulating core psychopathology
of AN and the expressions of this.
Effect of symptoms
Some features of AN can be difficult to assess meaning-
fully in that they decrease in ‘severity’ as illness severity
increases. For example, fear of fatness can decrease as
the individual’s weight drops and they are no longer
confronted with fat on their own body. Similarly, drive
for thinness and body image dissatisfaction can also
decrease as weight decreases. To generalist clinicians,
this could result in a failure to diagnose individuals with
potentially severe AN, as they appear to lack either oneor both of the essential symptoms. Other clinicians may
misconstrue this as ‘denial’ and engage in confrontational
discussions with patients, which may be unhelpful.
At very low weights, the effects of starvation will
always distort the expression of distress, and patients in
general are not necessarily aware of why they behave in
certain ways or why they may pursue certain goals. It
may be useful to assess certain symptoms from the per-
spective of what it would be like not to have them. For
example, assessing body dissatisfaction/drive for thinness
not from the standpoint of how the person with AN
feels about their body at its current weight, but rather
how they would feel about their body, and how intense
their drive to lose weight would be if they imagined their
weight being within a normal weight range, holds some
utility [36].
Culture and ethnicity
AN may present differently in people with a non-Western
background (see Soh et al. [37] for a review), and there are
significant body composition differences across ethnicities.
For example, Asian women show higher levels of body fat
for the same BMI than their Western peers [38]. There is
more mixed evidence that cultural issues influence psy-
chological symptom variability. While a commonly cited
difference is that fear of fatness is less evident in patients
from a non-Western background, many studies do not
show this [39]. Likewise, levels of body image disturbance
amongst clinical groups from different cultures have been
found to be largely identical despite genuine cultural dif-
ferences in body image concern in those who do not have
an ED [40]. Studies that have historically highlighted
symptom variability across cultures have commonly exam-
ined ethnic minorities residing in Western countries:
when an ethnic group is studied in their country of origin,
many of the proposed differences in clinical presentation
cannot be found. Likewise, struggles with psychological
control reported in AN appear universal, but importantly
it is deviation from the cultural norm (whatever the cul-
ture) that seems to distinguish women with EDs from
their peer group [41]. In short, rather than ethnicity
explaining any noted symptom variations, the pertinent
assessment issues may relate to understanding the current
cultural norms and their dissonance with the culture of
their ethnic background.
Gender
Although representing around one in ten people with AN
[42], males with this condition are much less likely to be
recognised. Amongst those who do present for assess-
ment, medical complications are more likely apparent
than with their female counterparts [43]. There are mixed
views about whether males present for assessment much
earlier (see Carlat et al. [44]) or later (see Siegel et al. [43])
Surgenor and Maguire Journal of Eating Disorders 2013, 1:29 Page 5 of 12
http://www.jeatdisord.com/content/1/1/29than their female counterparts. Psychological symptoms
are largely identical, although there is some limited evi-
dence that males may have less severe scores on diagnostic
tools and symptom rating scales [45] and are more likely
present with particular weight control strategies (for
example, excessive exercise [46]) and dissatisfaction with
muscle size and shape. Too few studies have been
conducted to examine whether the natural course of the
illness differs by gender. Some studies report a more
benign outcome in men at one year (e.g. Strober et al.
[47]), while a recent long term follow-up study found no
gender differences in 10-year survival rates [48]. Causal
models particularly relevant to males are still largely
speculative, although sexual orientation issues feature
prominently in males [49]. However it may be that gay
men may be more willing to seek help for psychological
problems. At this stage therefore, the assessment of
males presenting with AN largely should follow the
same assessment considerations as females.
Assessment screening and severity tools
Screening tools
A large number of standardised self-report and interview-
based measures are available to clinicians. There is long-
standing debate about the superiority of interviews as
opposed to self-report measures (whether paper and
pencil or computerised), and ultimately the selection of
any measure will depend on the purpose and context of
assessment, along with constraints on time, availability
of training and clinical factors. These issues are now
discussed.
Self-report questionnaires are easy and quick to ad-
minister, although they differ in their utility. Shorter
measures such as the Eating Attitudes Test (EAT-12;
EAT-26) [50] and SCOFF [10] are useful in primary care
situations where an ED may be suspected (NICE Guide-
lines; Allen et al., 2011), and identifying the need for sec-
ond screening steps is a focus. However these are less
useful in specialist settings where the more relevant task
is to gather systematic information about severity and
the extent of psychopathology. Here, longer self-report
measures (for example, Eating Disorder Inventory (EDI-3)
[51], Eating Disorder Examination Questionnaire (EDE-Q)
[52], and Yale-Brown-Cornell Eating Disorders Scale
(YBC-EDS, [53]) tend to assess two factors - a combin-
ation of risk factors and psychological disturbances as-
sociated with AN [54]. Detailed information about
psychological symptoms can be elicited from these,
which in turn adds to any clinical formulations. As
standardised measures, they can be useful in assessing
symptom change.
Semi-structured or structured clinical interviews such
as the Structured Clinical Interview for DSM-IV Axis I
Disorders Clinical Version (SCID-CV) [55], and EatingDisorder Examination (EDE) [56] are often referred to as
“gold standards” (APA, 2006, p.46). These are more
time-consuming, involve training and are more likely
suitable for research purposes rather than clinical set-
tings, although they do possess the advantage of being
validated to render an ED diagnosis.
Irrespective of the measure used, scores are affected
by a number of clinical, demographic and psychometric
issues. Denial may occur in interviews due to embarrass-
ment and reluctance to disclose, whereas the risk with
self-report measures is that patients may inaccurately es-
timate the seriousness of core symptoms [57,58], or sim-
ply disagree that symptoms are problematic [59]. In very
severe cases, administration of psychometric tests (AN-
related or otherwise) is clearly inappropriate. Wider
psychometric limitations arise from differences in inter-
national norms and few national clinical norms [54], and
the utility of measures differ between adults and adoles-
cents [60]. Furthermore, different formats of the same
measure (e.g. EDE and EDE-Q) have only modest agree-
ment ratings, with rates of agreement being dependent
on the type of symptom being assessed [58]. In terms of
AN, no measure reliably distinguishes between AN and
EDNOS-AN [61].
A positive diagnosis can be made in most cases with-
out the need for a battery of psychometric tests. The
more useful place of standardised psychometric tools is
to screen, assess symptom change and research. In the
end, standardised psychometric tools cannot replace the
advantages of a thorough clinical interview. As noted by
Nordbø et al. [62], “an assessment tool should never be
regarded as a substitute for treating the patients indi-
vidually or replace the need for an individual exploration
in each single patient” (page 660). This is further
discussed in the final section of this paper.
What constitutes severity?
The use of the concept of illness severity is common in
ED settings, and there are solid grounds for this. For ex-
ample, severity markers can help aid treatment deci-
sions, potentially aid prognosis, and promote more
uniform international understandings about clinical pre-
sentations [63]. However, empirically supported defini-
tions of severity are largely lacking. Clinicians commonly
default to one or more symptom markers or treatment
intensity markers such as BMI [64] or multiple severity
indices based on different symptoms (not all of which
are AN symptoms [65]), hospitalisation [66] or length of
illness [67]. In an attempt to address problems with all
of the above strategies, a more recent approach has been
the development of empirically derived tools to stage
AN severity [36,68]. Early indicators suggest that such
measures involve multiple symptom dimensions, and
neatly capture both clinical reality and patient subjective
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largely assess the behavioural features of the ED so as to
minimise the factors of denial and the often perverse re-
duction in psychological distress discussed above, as the
illness progresses (i.e. drive for thinness and body dissatis-
faction can decrease with severity). Longitudinal data is
still needed to determine how staging instruments could
usefully aid assessment, treatment pathway decisions and
the prediction of prognosis.Family involvement and family assessment
Where possible, it is highly desirable to have carers or
family involved in the assessment process given they pro-
vide much of the on-going care and share the extensive
burden of the disorder. For younger patients still living at
home, family members may need to be directly involved
as treatment agents [69] as long as they are appropriately
supported and advised, noting that family members can
become entangled with behaviours that maintain the
disorder [70]. For adolescents, the assessment phase may
more directly involve assessment of family functioning.
The inevitable distress about having a family member with
AN may need addressing in its own right and assessment
of family functioning is core where family therapy treat-
ment models are to be employed. There is no clearly
superior way to assess family functioning: approaches are
likely to reflect the model of family therapy employed and
there are several variants of this. Family therapy models
have been met with enthusiasm although a recent
Cochrane Collaboration review suggests a need to temper
this enthusiasm due to a range of methodological short-
comings in the small number of published treatment trials
[71]. Such moderation should equally apply to assessment
processes meaning that rigid approaches to assess families
should be avoided.Co-morbidity
Given psychiatric co-morbidity is common in people with
AN, consideration of these associated problems should be
routine. Those presenting for assessment may have higher
rates of co-morbidity than AN community samples due to
the additional burden and distress of these comorbid con-
ditions. Indeed, these conditions may be the precipitant
for presentation rather than AN itself. If psychiatric co-
morbidity is recognised, conclusions about the actual
presence of a primary anxiety (or mood disorder) is often
best delayed until the symptom contribution of AN can be
clarified, especially in the case of severe AN. Co-morbidity
may impact on treatment engagement, in both directions,
with co-morbidity prompting assessment or in other cir-
cumstances reducing engagement. The following sections
discuss common forms of co-morbidity and implications
for assessment.Mood disorders
While major depression features prominently, depressive
symptoms may also result from severe malnutrition,
which almost certainly elevate these rates. Generally,
however, there is robust evidence for elevated rates of
major depression in all AN populations, irrespective of
whether these are clinic or community samples. Godart
et al. [72] found life-time prevalence rates ranging from
9.5% - 71.3%, with the variability in findings likely due to
methodological differences across studies. The overall
lifetime prevalence for eating disorders patients is esti-
mated at 40%. There is debate about the most common
sequencing of these comorbidities with some suggesting
that the mood disorder more often precedes the ED
(Cooper et al., 2002) and others highlighting past
problems of over-diagnosing depression when instead
symptoms may be secondary to malnutrition [57]. The
consensus is that the relationship is complex. Scores on
depression screening measures can be significantly ele-
vated by an ED [73] resulting in a need to set higher
cut-off scores in order to be meaningful. Vigilance for
mood symptoms should also be ongoing given that im-
provements in AN can be experienced as depressogenic,
with some sufferers construing the relinquishing of
symptoms as a sign of losing control or giving in (to
treatment) [74].
Bipolar disorder co-morbidity in AN is rare [75].
Affective disorders along this spectrum are more likely
to be associated with forms of disordered eating in-
volving bingeing or over-eating. How EDs and bipolar
disorders overlap requires further study.
Assessment of self-harm and suicide risk
A recent meta-analysis observed a decreased risk of
completed suicide in AN [76] over recent decades, with
a standardised mortality ratio (SMR) of 31. This SMR
still represents an elevated risk when compared with
other EDs and the general population. The extent to
which AN directly contributes to this risk as opposed to
the combined effects of AN and co-morbidity to this risk
is still debated [77].
Information gathering about risk comprises a two
stepped approach. First, standard suicide self-harm risk
assessment considerations apply. Thus, just with non-ED
populations, the presence of depression increases the
risk of suicidal behaviours and completed suicide and a
sizeable proportion of these people will have had contact
with their GP in the week or months before death. Other
risk factors include a history of mental disorder, more se-
vere psychopathology overall, Axis 2 psychopathology, his-
tory of self-harm/suicide attempts, and substance misuse
(see Hawton et al. [78]). It follows that assessment of these
standard risk factors should always occur when engaging
with a person presenting with AN.
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history of AN may produce additional risks. These in-
clude the presence of binge-purge patterns [79], markers
of chronicity including illness duration and very low
weight [80], and high anxiety in AN-R [79]. Rates of
completed suicides in people with AN are debated [2],
with one study reporting suicide as the second most
frequent cause of death in a retrospective study of those
treated in an ED service [81]. The most consistent find-
ing is approximately 20% of deaths in AN are attribut-
able to suicide [82]. It is self-evident that assessment of
suicidal ideation and behaviours is important, especially
in those presenting with co-morbidity.
Unusual forms of self-harm have been reported that are
directly linked with efforts to maintain AN. For example,
ingesting large quantities of salt [83], scratching [84] and
blood-letting [85]. How these phenomena fall under the
umbrella of wider deliberate self-harm (DSH) phenomena
is unclear as DSH has multiple intended functions [86].
If present, such behaviours are unlikely to come to light
in outpatient assessment settings. Although the con-
scientious clinician will assess for them, these may only
be revealed following close monitoring, as occurs in
inpatient settings.
Anxiety disorders
There is extensive overlap between anxiety and AN symp-
toms, with AN exacerbating concurrent anxiety disorders
in addition to extensive anxiety symptoms forming part of
the AN syndrome [87]. This makes assessment of anxiety
a necessary component of any formulation, irrespective of
any suspected Axis 1 anxiety disorder. This is because
common anxiety treatment techniques inevitably will
be part of treatment. Assessment questions include the
extent of pre-morbid anxiety, the presence of genuine
co-morbidity and the degree to which anxiety symptoms
are actually part of AN. These issues are addressed
in turn.
Reported lifetime prevalence rates of anxiety disorders
vary considerably ranging from 23%-75% (see Swinbourne
and Touyz [88] for a review). Generally the anxiety dis-
order is more likely to precede the onset of AN rather
than the other way around [89], although this may depend
on the anxiety disorder in question [90]. Of the anxiety
disorders, obsessive-compulsive disorder (OCD) is the
most researched condition [91], although social phobia,
other phobic states and Generalised Anxiety Disorder
(GAD) and anxiety-based problems such as clinical perfec-
tionism [92] have all received attention.
Teasing out the functional relationship between wider
anxiety phenomena and/or the presence of a primary anx-
iety disorder can be challenging, and even after weight-
restoration anxiety symptoms tend to persist [93]. Detailed
functional analysis of behavioural and cognitive rituals, thescope of intrusive thoughts, the scope of avoidance, and
any other symptoms of fear may help clarify how these
features are directly part of AN or more correctly attrib-
uted to another primary anxiety disorder. Importantly,
anxiety symptoms may not be reported due to the success
of avoidance or engaging in subtle “safety behaviours” that
keep symptoms at bay. In such cases, anxiety symptoms
may only emerge once there are treatment demands for
change. As a result, the absence of anxiety symptoms on
initial assessment should not be taken as evidence of the
absence of anxiety.
Obsessions and compulsions particularly increase with
starvation, and sometimes to an intensity that is compar-
able to people with OCD. Conclusions about the presence
of a primary anxiety disorder should wait until the effects
of starvation have abated.Substance abuse and dependence
Reported rates of substance abuse in AN vary widely
and are significantly associated with AN subtype (binge/
purge), with rates as high as 35% in those who cross over
to Bulimia Nervosa (BN) after weight restoration [94]. In
general, the presence of any bulimic symptomatology
significantly increases the likelihood of co-morbidity in-
volving a variety of substances, both illicit and legal
[95,96]. The sequencing of co-morbid alcohol problems
and AN shows no distinctive pattern [97]. However the
concurrent presence of alcohol misuse and AN should
prompt enquiry into wider psychopathology given the
increased odds of this in this subpopulation [98] and the
known increased mortality [2].
Other substance abuse and dependence problems in-
clude the use of diet pills, laxatives, diuretics and other
illicit stimulants for appetite suppression and increased
metabolic effects [99]. Opioid and sedative use is also
significantly elevated. In short, the assessment of sub-
stance misuse should cast a wide net, seeking informa-
tion about illicit and over-the-counter drugs, including
common substances containing high levels of caffeine.
The assessment should also include patient understand-
ings about how these substances maintain AN symptoms
(for example, warding off normal signals of hunger) or
manage other psychological symptoms or distress.Nutritional, weight, and eating behaviour assessment
Obtaining a weight and nutritional history is a critical
component of assessment, although this can be far from
straight-forward. Being asked to be weighed is one of the
most anxiety-provoking demands for someone with AN,
even when many know their weight due to excessive
self-monitoring. In the situation of outright refusal to be
weighed, this can be a temporary impasse if the anxiety
about this is explored. Clinicians who allow the continued
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inadvertently colluding with the disorder.
Body mass index (BMI) is the most common metric
used, with extreme levels (BMI ≤ 13) consistently showing
a risk of a poorer outcome and elevated medical risks
[81,100]. Centile charts are recommended for patients
who are younger than 18 years of age [101]. Percentage of
body fat is another useful indicator of risk as this also has
been associated with outcome [102].
Apart from ascertaining current weight, there are several
aspects of weight history that are clinically important.
These include obtaining information about highest and
lowest-ever weight (BMI), means of weight control, and if
amenorrhea is present, weight at which menses were lost
or in the case of primary amenorrhea consideration of the
effect of delayed puberty. A history of a very low BMI at
any point in the illness trajectory is a risk factor for pre-
mature death [2]. BMI alone is problematic in younger
populations for whom BMI-for-age is argued as more
appropriate [103]. Patient perception of their ‘ideal’
weight, and how they determined this, can provide use-
ful clinical information about maintaining factors, and
how AN is serving to manage psychological difficulties.
Commonly, a particular weight may be fixated upon
with an expectation that achieving this will bring a sense
of well-being and success. Inevitably such rewards are not
forthcoming often resulting in a decision to work towards
a lower weight - as if the original goal was miscalculated.
A food and fluid diary may help assess aspects of nutri-
tional pathology, or at least start the discussion about
nutritional intake. Shame, embarrassment, and anxiety
about increasing nutritional intake, are amongst the fac-
tors that affect the accuracy of food diaries and other
forms of self-recording. Additional enquiry should be
made about avoided foods, behaviours and rituals around
eating, evidence of self-imposed caloric limits, and the full
repertoire of compensatory behaviours.
Medical assessment
The main causes of increased mortality in AN are those
directly related to the disease [82]. Fortunately advances in
assessment and careful treatment of AN-related medical
abnormalities have helped reduce the rates of mortality
[104] compared with earlier practices. Multiple organ
systems should be reviewed at assessment and abnormal
medical findings can provide compelling objective evi-
dence to ambivalent attendees who may contest the need
for treatment. The types of medical complications present-
ing are influenced by age, clinical history, and weight his-
tory. The extent of medical and physical investigations
undertaken will depend on these factors although there is
some consensus on commonly recommended laboratory
investigations. These include a full blood count, urea and
electrolytes, biochemistry including calcium, magnesium,and phosphate, and glucose and liver functioning [105].
Assessment and monitoring for phosphate depletion is
particularly important. Hypophosphatemia is well known
to be associated with catastrophic consequences in the
context of refeeding particularly for the severely under-
weight person.
Of concern, complications that are not reversible can
occur in those who have yet to develop a chronic problem,
and these include altered linear growth, osteoporosis, and
structural or functional brain changes [106]. It is import-
ant to recognise that patients may initially appear asymp-
tomatic due to slow adaptation to starvation over time.
More detailed medical assessments may be indicated for
those presenting with severe AN, as it is a mistake to con-
sider mild AN as a benign condition. Even those with mild
AN may experience prolonged periods of debilitating
symptoms [11].
A full medical history and physical examination is es-
sential to highlight immediate medical problems such as
hypotension, hypothermia, bradycardia, skin conditions,
and intercellular changes such as dehydration. Enquiry
should extend to other gastrointestinal problems such
as diarrhoea, constipation and abdominal cramping. A
small number of patients may have had extensive previ-
ous medical work-up in an attempt to locate a medical
condition that could explain symptoms that are more
correctly caused by AN. Likewise, although rare, other
non-psychiatric causes of significant weight loss (for ex-
ample, medical conditions resulting in mal-absorbing
consequences) should be considered early in the assess-
ment process.
A medical review should include considering the pres-
ence of other conditions that may have serious conse-
quences while occurring in the context of AN (e.g.
diabetes) or other causes of weight loss unrelated to AN
(e.g. primary gastrointestinal disorders), along with a
review of medications that may compromise or contrib-
ute to medical risks occurring (for example, medications
that prolong QT intervals). Since cardiac abnormalities
have been estimated to occur in up to 86% of patients
[107], and cardiovascular causes are a major cause of
death [108], cardiac investigations (ECG) should check
for a range of cardiomyopathies, of which there are
many [109]. Studies suggest that is unclear when QT
prolongation first occurs in the natural history of AN
and when the period of greatest risk of cardiac abnor-
malities may occur [107]. Endocrine screens are useful,
particularly checking thyroid functions and other hormo-
nal disturbances.
Other checks may need to include bone density scans
assessing for osteoporosis and spontaneous or low impact
fractures, particularly if pain is a presenting complaint.
When symptoms of self-induced vomiting are present, the
risk of dental complications is high even after a relatively
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recommended. Common gastrointestinal disturbances in-
clude gastric pain, prolonged gastric emptying and consti-
pation [108], all of which can perpetuate the desire to
continue restricting.
The presence of medical complications may or may not
lead to hospital admission. As noted earlier, significant
contextual factors, availability and regional treatment phil-
osophies influence admission decisions [111] both within
and between countries. When acute medical presentations
occur, particular care is needed to avoid the refeeding syn-
drome and other treatment-related complications. Medical
symptoms may be alarming and prompt consideration of
urgent steps, but cautious use of otherwise considered
routine interventions (for example, intravenous fluids) is
required in order to avoid catastrophic consequences
[112]. A small number of patients will require an explicit
medical admission.
Compulsory assessments
On occasions, preliminary assessments occur under
duress after formal steps have been taken to initiate the
assessment. Engagement of a reluctant patient who may
require persuasion, formal or otherwise, to accept ur-
gent investigations or treatment requires skill and tact.
The legal options and legislative pathways for compul-
sory assessment vary across countries, but the principles
are relatively universal and well discussed in the litera-
ture [113,114]. Legal coercion is required relatively
infrequently [115]. Importantly, patient perceptions of
coercion, with or without the use of formal compulsion,
occur along a continuum [116] with many later describ-
ing formal treatment orders as helpful. Much can be
done to mitigate distress when a compassionate and
trusting approach is taken [117]. Decision-making must
consider patient capacity to make decisions, the urgency
of presenting symptoms and the outcomes where com-
pulsory steps have been previously utilised to detain the
patient.
Synthesis and formulation of assessment information
A comprehensive assessment interview is likely to take
several hours, and where clinically indicated, may re-
quire several appointments. Once sufficient and neces-
sary information has been gathered, the next step is to
synthesise this with other findings from other standard
assessment steps such as history taking and mental
status examination.
A case formulation approach is recommended to
develop “a more complete picture of the patient than
can be associated with a diagnosis” [[118], page 1] in-
corporating all presenting issues, past treatment out-
comes and patient perspectives. It involves assimilating
information from multiple sources and using clinicaljudgement to weigh up both converging and conflicting
data. A case formulation approach is also conducive to
building a therapeutic alliance which is vital in psycho-
therapeutic treatments both generally and specifically in
regarding to AN [119].
The formulation may include tentative hypotheses
about predisposing, precipitating and maintaining factors.
Families commonly ask about causal factors fearing that
assessment findings will implicate them in some way.
Pressed for answers from distressed families (and patients
themselves), clinicians may be tempted to be drawn on
predisposing factors. However causes of AN are far from
understood. Tentative hypotheses are best, and better
framed as general risk factors in the interim. Given the
typically prolonged time between onset and assessment
combined with difficulties establishing age of onset, articu-
lating more immediate precipitating factors is equally
fraught. It will be more possible to draw conclusions about
maintaining factors due to the extensive knowledge about
reinforcement schedules and behavioural traps in the lived
experience of AN.
In a large multidisciplinary team, varying perspectives
and formulations may emerge and this can be clinically
useful. However such differences should never divert from
the importance of all team members uniting behind any
arising triage or treatment plan. The end result of the case
formulation should be a set of working hypotheses articu-
lated into a coordinated care plan followed by all team
members. This care plan should be both detailed and
broad covering immediate treatment needs and priorities
for further investigation.
Conclusion
This overview in limited in its ability to fully discuss all
relevant factors in assessment; a decision was made to
include issues that would be pertinent to a wide audience.
Likewise, the scope of this overview precludes discussion
of the steps instigating treatment following from assess-
ment, although it follows that management of acute phys-
ical and psychiatric problems naturally take priority.
Experienced clinicians know that the process of assess-
ment is an on-going one, encompassing a need to repeat
and monitor medical investigations and revise psycho-
logical formulations as more information comes to light,
symptoms worsen or improve and priorities shift. A pre-
liminary assessment should never attempt to reach firm
opinions about cause although formulations relating to
factors maintaining the disorder may be more apparent.
In conclusion, assessments require a systematic, rigor-
ous, and empathic approach that strikes an important
balance between carefully listening to patient needs and
dilemmas, while remaining firm and focused about the
need for treatment. Even difficult assessment interviews
conducted under duress should leave the patient with a
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sessment interaction should be seen as an important
therapeutic interaction to begin building a therapeutic
alliance, balancing both an atmosphere of acceptance
[120] yet firmness without being over-confident or
paternalistic. The most important assessment tool is the
clinician and the knowledge and stance they take into
the interpersonal interaction. An assessment will always
be a deeply complex interpersonal interaction requiring
a careful clinical interview, and one based on a sound
understanding of the symptoms and issues faced by the
patient.
On-going efforts are required to address substantive
knowledge gaps and to encourage the uptake of evidenced-
based approaches where such evidence is assessed as
strong. As noted recently, “the bond that tethers our patient
to our treatment is a fragile one” [[121], page 178]. At times
this could be rephrased to say that the bond that tethers
assessing clinicians to the evidence is equally fragile. There
is a universal problem transferring research evidence into
clinical practice, and this overview aims to reduce that
‘leakage’ [122] between research and practice.
While not above criticism themselves, a number of
practice guidelines are available that outline in some de-
tail the required and desired assessment investigations,
and at least draw clinicians’ attention to the quality and
limitations of evidence. These include the Australasian
[123] (currently undergoing review), North American
[124], and the British [101] guidelines. The latter of
these (and the most recently published) appeared just
under a decade ago, but a recent review of the literature
indicates that these guidelines are as relevant today as
they were in 2004, (http://www.nice.org.uk/nicemedia/
live/10932/55781/55781.pdf, downloaded 17 Sept 2012).Competing interests
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